Stark Law

Indiana Hospital System Agrees to Pay United States $345M to Settle Claims of Medicare Fraud Brought by CFO-turned-whistleblower, Represented by Joseph Greenwald & Laake

Retrieved on: 
화요일, 12월 19, 2023
CHN, Community, Partnership, Veronica, State, Stark Law, Government, Physician, LLP, False Claims Act, Complaint, FCA, Fraud, DOJ, Knowledge, Medicare, Stark, Patient, Employment, Corporation, Pharmaceutical industry

INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ -- The United States Department of Justice (DOJ) today announced a settlement with Indiana-based Community Health Network (Community) for $345 million for healthcare fraud claims on Medicare. The False Claims Act (FCA) case spanned 2008 to 2020. This historic settlement comes more than nine years after it was first filed. Community must also comply with a Corporate Integrity Agreement, ensuring five years of continual monitoring by the government. This is the second settlement with recidivist offender Community; the first was 2015 for $20.3 million.

Key Points: 
  • The settlement comes after seasoned healthcare finance and operations executive Thomas Fischer sued his former employer, Community.
  • Fischer is a whistleblower, or "relator," under the FCA, who filed suit on behalf of the government based on detailed insider knowledge of fraud.
  • Today's $345 million settlement is reportedly nearly triple the largest prior Stark Law False Claims Act settlement.
  • These claims are not mere technicalities; they directly affect patients, hospital employees and the high cost of healthcare.

Former DOJ Trial Attorney Michael Shaheen Returns to Crowell & Moring

Retrieved on: 
목요일, 11월 9, 2023
Quinn Emanuel Urquhart & Sullivan, Stark Law, Cornell Law School, Government, United States Justice Department investigation into attempts to overturn the 2020 presidential election, Crowell & Moring, Justice minister, Lawyer, Risk, False Claims Act, White collar, Anti-Kickback Statute, Saolta University Health Care Group, Office of Inspector General, U.S. Department of Health and Human Services, FCA, Vanderbilt University, DOJ, Pharmaceutical industry

WASHINGTON, Nov. 9, 2023 /PRNewswire/ -- Michael Shaheen , former trial attorney in the U.S. Department of Justice Commercial Litigation Branch's Fraud Section, has rejoined Crowell & Moring.

Key Points: 
  • WASHINGTON, Nov. 9, 2023 /PRNewswire/ -- Michael Shaheen , former trial attorney in the U.S. Department of Justice Commercial Litigation Branch's Fraud Section, has rejoined Crowell & Moring.
  • Shaheen returns as a partner in the firm's Health Care Group where he will focus on False Claims Act cases and healthcare fraud and abuse.
  • While at the Justice Department, Shaheen's roles on False Claims Act cases ranged from lead investigator to first chair trial attorney.
  • He was an associate at an AmLaw 100 firm prior to joining the DOJ in 2014.

Greenberg Traurig Deepens Health Care Regulatory and Data Privacy Footprint in Philadelphia with Brad M. Rostolsky and Catherine E. David Galea

Retrieved on: 
화요일, 8월 8, 2023
Cate, Emory University, LLP, Duquesne University, Stark Law, Anti-Kickback Statute, Senior counsel, Public, Greenberg Traurig, Medicine, Privacy, Element, Drexel University, District court, Hospital, Thomas R. Kline School of Law of Duquesne University, Centers for Medicare & Medicaid Services, Thomas, Dickinson College, Reed Smith, FDA, Douglas v. U.S. District Court ex rel Talk America, Mid-Atlantic (United States), HIPAA, Retail, Nursing

PHILADELPHIA, Aug. 8, 2023 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP added two attorneys to its Health Care & FDA Practice in Philadelphia: Brad M. Rostolsky joined as a shareholder and Catherine E. David Galea joined as of counsel.

Key Points: 
  • Global law firm Greenberg Traurig, LLP added two attorneys to its Health Care & FDA Practice in Philadelphia: Brad M. Rostolsky joined as a shareholder and Catherine E. David Galea joined as of counsel.
  • PHILADELPHIA, Aug. 8, 2023 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP added two attorneys to its Health Care & FDA Practice in Philadelphia : Brad M. Rostolsky joined as a shareholder and Catherine E. David Galea joined as of counsel.
  • Rostolsky comes to Greenberg Traurig after spending the bulk of his career at Reed Smith where Galea worked alongside him.
  • I've long been impressed by the entrepreneurial spirit and constant innovative approaches for which Greenberg Traurig is known," Rostolsky said.

Greenberg Traurig's Jessica Natali and Andrew Tsui to Co-Present at 2023 Association of Corporate Counsel of Greater Philadelphia's In-House Counsel Conference

Retrieved on: 
월요일, 4월 17, 2023
Supreme, ACC, LLP, Stark Law, Medicaid, Office of Inspector General, U.S. Department of Health and Human Services, Education, General counsel, Anti-Kickback Statute, Accountable care organization, False Claims Act, Natali, Government, Medicare, Laboratory, Office of the General Counsel for the Department of the Treasury, Supreme court, Corporate lawyer, FDA, Conference, HIPAA, Insurance, Delaware Valley

PHILADELPHIA, April 17, 2023 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP White Collar Defense & Investigations Practice Shareholder Jessica Natali and Health Care & FDA Practice Of Counsel Andrew Tsui will co-present on health care enforcement and compliance at the 2023 Association of Corporate Counsel (ACC) of Greater Philadelphia's In-House Counsel Conference.

Key Points: 
  • Global law firm Greenberg Traurig, LLP White Collar Defense & Investigations Practice Shareholder Jessica Natali and Health Care & FDA Practice Of Counsel Andrew Tsui will co-present on health care enforcement and compliance at the 2023 Association of Corporate Counsel (ACC) of Greater Philadelphia's In-House Counsel Conference.
  • PHILADELPHIA, April 17, 2023 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP White Collar Defense & Investigations Practice Shareholder Jessica Natali and Health Care & FDA Practice Of Counsel Andrew Tsui will co-present on health care enforcement and compliance at the 2023 Association of Corporate Counsel (ACC) of Greater Philadelphia's In-House Counsel Conference .
  • Natali and Tsui will co-present "Emerging Healthcare Enforcement & Regulatory Compliance Trends and Implications – Views from Former Agency Counsel, In-House Counsel and Outside Counsel" April 20.
  • They will discuss navigating critical fraud and compliance issues based on their experience as former government attorneys and current in-house counsel.

McDermott Adds Depth to Healthcare Practice with Partner Rehire in Washington

Retrieved on: 
화요일, 1월 31, 2023
University, Big Law: Deputy Butterbean, American University, Fraud, PitchBook Data, McDermott Will & Emery, Culture, Medicare Part D, Centers for Medicare & Medicaid Services, Medicare, Chambers and Partners, Stark Law, Federal, McDermott, News, US, Federation, False Claims Act, Standings, Chambers, International law, Health care, JD, Washington College of Law, BS, Pharmaceutical industry

WASHINGTON, Jan. 31, 2023 /PRNewswire/ -- International law firm McDermott Will & Emery is pleased to announce the return of partner Nicholas (Nick) Alarif to the Healthcare Practice Group in Washington, DC. Previously a partner at the Firm and most recently serving as in-house counsel to the country's largest nonprofit health system, Nick's practice primarily focuses on healthcare regulatory matters with an emphasis on fraud and abuse and other healthcare compliance situations.

Key Points: 
  • Partner Nick Alarif Strengthens Fraud and Abuse, Regulatory Compliance Teams
    WASHINGTON, Jan. 31, 2023 /PRNewswire/ -- International law firm McDermott Will & Emery is pleased to announce the return of partner Nicholas (Nick) Alarif to the Healthcare Practice Group in Washington, DC.
  • "We are excited that Nick enjoyed working at McDermott and has chosen us for his return to Big Law.
  • McDermott is the nation's leading healthcare law firm and the only healthcare practice to receive top national rankings from U.S. News – Best Lawyers "Best Law Firms," Chambers USA, The Legal 500 US and Law360.
  • McDermott has also held the top spot in PitchBook's League Tables as the most active firm for healthcare private equity since 2017.

CONTINUED INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT

Retrieved on: 
수요일, 1월 18, 2023
News, Genetics, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Anti-Kickback Statute, Privacy Office of the U.S. Department of Homeland Security, Remuneration, Justice, Battle of Saint-Fulgent, Stark, Disclosure, Law, Pharmaceutical industry

NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders.

Key Points: 
  • NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders.
  • If you are a Fulgent shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] .
  • If you are a Fulgent shareholder, you may have legal claims against Fulgent’s directors and officers.
  • If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982 or [email protected] .

INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT

Retrieved on: 
화요일, 1월 10, 2023
Class Action Lawsuit, Professional Services, Legal, News, Genetics, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Anti-Kickback Statute, Privacy Office of the U.S. Department of Homeland Security, Remuneration, Justice, Battle of Saint-Fulgent, Stark, Disclosure, Law, Pharmaceutical industry

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders.

Key Points: 
  • Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders.
  • If you are a Fulgent shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] .
  • If you are a Fulgent shareholder, you may have legal claims against Fulgent’s directors and officers.
  • If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982 or [email protected] .

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT

Retrieved on: 
월요일, 11월 28, 2022
Class Action Lawsuit, Professional Services, Legal, U.S. Department of Justice Office of Legislative Affairs, Disclosure, Law, Stark, Stark Law, Genetics, Battle of Saint-Fulgent, Privacy Office of the U.S. Department of Homeland Security, News, Anti-Kickback Statute, Justice, Remuneration, Pharmaceutical industry

Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, is investigating certain directors and officers of Fulgent Genetics, Inc. (Fulgent) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders.

Key Points: 
  • Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, is investigating certain directors and officers of Fulgent Genetics, Inc. (Fulgent) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders.
  • If you are a Fulgent shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] .
  • If you are a Fulgent shareholder, you may have legal claims against Fulgents directors and officers.
  • The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
월요일, 11월 21, 2022
Law, Stark Law, Genetics, IPO, Defendant, Battle of Saint-Fulgent, Anti-Kickback Statute, Suite, Investment, Remuneration, Security (finance), Mail, Holding company, Risk management, Barclays

LOS ANGELES, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles